Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   Grassypeptolides F and G, Cyanobacterial Peptides from Lyngbya majuscula
  2. Popplewell, W. L.; Ratnayake, R.; Wilson, J. A.; Beutler, J. A.; Colburn, N. H.; Henrich, C. J.; McMahon, J. B.; McKee, T. C.
  3. Journal of Natural Products. 2011, Aug; 74(8): 1686-1691.
  1. 2.   Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas
  2. Ikeuchi, H.; Kinjo, T.; Klinman, D. M.
  3. Cancer Prevention Research. 2011, May; 4(5): 752-757.
  1. 3.   A selective small-molecule nuclear factor-kappa B inhibitor from a high-throughput cell-based assay for "activator protein-1 hits"
  2. Kang, M. I.; Henrich, C. J.; Bokesch, H. R.; Gustafson, K. R.; McMahon, J. B.; Baker, A. R.; Young, M. R.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2009 8(3): 571-581.
  1. 4.   Targeting Transcription Factors for Cancer Prevention-the Case of Nrf2
  2. Colburn, N. H.; Kensler, T. W.
  3. Cancer Prevention Research. 2008 1(3): 153-155.
  1. 5.   Effects of o-aminoazotoluene on liver regeneration and p53 activation in mice susceptible and resistant to hepatocarcinogenesis
  2. Timofeeva, O. A.; Eremeev, A. V.; Goloshchapov, A.; Kalashnikova, E.; Ilnitskaya, S.; Setkov, N. A.; Kobzev, V.; Buzard, G. S.; Filipenko, M. L.; Kaledin, V.; Merkulova, T. I.
  3. Toxicology. 2008 254(1-2): 91-96.
  1. 6.   Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
  2. Wei, Q.; Jiang, H.; Matthews, C. P.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(50): 19738-19743.
  1. 7.   AP-1 a target for cancer prevention
  2. Matthews, C. P.; Colburn, N. H.; Young, M. R.
  3. Current Cancer Drug Targets. 2007, Jun; 7(4): 317-324.
  1. 8.   Fra-1 a target for cancer prevention or intervention
  2. Young, M. R.; Colburn, N. H.
  3. Gene. 2006, Sep; 379: 1-11.
  1. 9.   Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation
  2. Nunez, N. P.; Oh, W. J.; Rozenberg, J.; Perella, C.; Anver, M.; Barrett, J. C.; Perkins, S. N.; Berrigan, D.; Moitra, J.; Varticovski, L.; Hursting, S. D.; Vinson, C.
  3. Cancer Research. 2006, MAY 15; 66(10): 5469-5476.
  1. 10.   Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis
  2. Zudaire, E.; Martinez, A.; Garayoa, M.; Pio, R.; Kaur, G.; Woolhiser, M. R.; Metcalfe, D. D.; Hook, W. A.; Siraganian, R. P.; Guise, T. A.; Chirgwin, J. M.; Cuttitta, F.
  3. American Journal of Pathology. 2006, JAN; 168(1): 280-291.
  1. 11.   Autoantigens act as tissue-specific chemoattractants
  2. Oppenheim, J. J.; Dong, H. F.; Plotz, P.; Caspi, R. R.; Dykstra, M.; Pierce, S.; Martin, R.; Carlos, C.; Finn, O.; Koul, O.; Howard, O. M. Z.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 854-861.
  1. 12.   Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: Protective and deleterious effects
  2. Grivennikov, S. I.; Tumanov, A. V.; Liepinsh, D. J.; Kruglov, A. A.; Marakusha, B. I.; Shakhov, A. N.; Murakami, T.; Drutskaya, L. N.; Forster, I.; Clausen, B. E.; Tessarollo, L.; Ryffel, B.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunity. 2005, JAN; 22(1): 93-104.
  1. 13.   Coordination mode and oxidation susceptibility of nickel(II) complexes with 2 '-deoxyguanosine 5 '-monophosphate and L-histidine
  2. Jezowska-Bojczuk, M.; Kaczmarek, P.; Bal, W.; Kasprzak, K. S.
  3. Journal of Inorganic Biochemistry. 2004, NOV; 98(11): 1770-1777.
  1. 14.   Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms
  2. Hou, D. X.; Kai, K.; Li, J. J.; Lin, S. G.; Terahara, N.; Wakamatsu, M.; Fujii, M.; Young, M. R.; Colburn, N.
  3. Carcinogenesis. 2004 25(1): 29-36.
  1. 15.   A tale of two tumor targets: Topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy
  2. Cragg, G. M.; Newman, D. J.
  3. Journal of Natural Products. 2004 67(2): 232-244.
  1. 16.   Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice
  2. Felix, K.; Gerstmeier, S.; Kyriakopoulos, A.; Howard, O. M. Z.; Dong, H. F.; Eckhaus, M.; Behne, D.; Bornkamm, G. W.; Janz, S.
  3. Cancer Research. 2004 64(8): 2910-2917.
  1. 17.   Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis
  2. Kim, D. J.; Akiyama, T. E.; Harman, F. S.; Burns, A. M.; Shan, W. W.; Ward, J. M.; Kennett, M. J.; Gonzalez, F. J.; Peters, J. M.
  3. Journal of Biological Chemistry. 2004 279(22): 23719-23727.
  1. 18.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 19.   Nitric oxide does not mediate but inhibits transformation and tumor phenotype
  2. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1285-1293.
  1. 20.   AP-1, NF kappa B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model
  2. Suzukawa, K.; Weber, T. J.; Colburn, N. H.
  3. Environmental Health Perspectives. 2002 110(9): 865-870.
  1. 21.   The effects of adrenomedullin overexpression in breast tumor cells
  2. Martinez, A.; Vos, M.; Guedez, L.; Kaur, G.; Chen, Z.; Garayoa, M.; Pio, R.; Moody, T.; Stetler-Stevenson, W. G.; Kleinman, H. K.; Cuttitta, F.
  3. Journal of the National Cancer Institute. 2002 94(16): 1226-1237.
  1. 22.   Protection against human papillomavirus type 16-E7 oncogene- induced tumorigenesis by in vivo expression of dominant- negative c-jun
  2. Young, M. R.; Farrell, L.; Lambert, P.; Awasthi, P.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2002 34(2): 72-77.
  1. 23.   Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently
  2. Young, M. R.; Nair, R.; Bucheimer, N.; Tulsian, P.; Brown, N.; Chapp, C.; Hsu, T. C.; Colburn, N. H.
  3. Molecular and Cellular Biology. 2002 22(2): 587-598.
  1. 24.   AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers
  2. Suzukawa, K.; Colburn, N. H.
  3. Oncogene. 2002 21(14): 2181-2190.
  1. 25.   Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. Ramakrishna, G.; Perella, C.; Birely, L.; Diwan, B. A.; Fornwald, L. W.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2002 179(1): 21-34.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel